Abstract

BackgroundAdherence to (non)pharmacological treatment is important in heart failure (HF) patients, since it leads to better clinical outcome. Although self-reported and objectively measured medication adherence in HF patients have been compared in previous studies, none of these studies have used an evidence-based cutpoint to differentiate between adherence and non-adherence.MethodsIn 37 HF patients (mean age 68 ± 10 years, 27 % female, 40 % NYHA functional class III-IV), medication (ACEi/ARB) adherence was objectively measured using the Medication Event Monitoring System (MEMS). Adherence to and importance of taking medication was also assessed by self-report using the Revised HF Compliance Questionnaire.ResultsAll patients reported that adherence was (highly) important to them and that they ‘always’ took their medication as prescribed (i.e. 100 % adherence). However, when measured by the MEMS, only 76 % of all patients were adherent. Non-adherent patients more often had a complex medication regimen (78 % vs. 21 %, P < .01), more often depressive symptoms (75 % vs. 29 %, P = .04) and a shorter history of HF (8 vs. 41 months, P = .04), compared with adherent patients.ConclusionsMedication adherence measured by the MEMS was remarkably lower than self-reported adherence. Given the evidence of its importance, further efforts are needed to improve adherence to the pharmacological regimen in HF patients.

Highlights

  • Adherence to the pharmacological regimen and nonpharmacological lifestyle changes is an important issue in heart failure (HF)

  • The mean age of the study population (n037) was 68±10 years, 27 % were female and 40 % were in New York Heart Association (NYHA) functional class III-IV at discharge, with a mean left ventricular ejection fraction (LVEF) of 33 %±13 (Table 1)

  • The main result of this study is that medication adherence objectively measured by Medication Event Monitoring System (MEMS) was remarkably lower than self-reported adherence

Read more

Summary

Introduction

Adherence to the pharmacological regimen and nonpharmacological lifestyle changes is an important issue in heart failure (HF). Adherence, defined as ‘the extent to which the behaviour corresponds with agreed recommendations from a healthcare provider [1]’, leads to better outcome in HF patients [2,3,4]. Medication adherence in HF patients is not optimal, with rates ranging from 10% to 96 % [7, 8], depending on measurement and definition of adherence. Adherence to (non)pharmacological treatment is important in heart failure (HF) patients, since it leads to better clinical outcome. Self-reported and objectively measured medication adherence in HF patients have been compared in previous studies, none of these studies have used an evidence-based cutpoint to differentiate between adherence and non-adherence.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call